Total Time: 22:42 | File Size: 10.3 MB
Topics covered in this edition:
Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes Â
Calorie Restriction and Matched Weight Loss From Exercise: Independent and Additive Effects on Glucoregulation and the...
View our Privacy Policy & Terms of Use
This free content is available to registered users.
Becoming a Registered User only requires your name and email address.
Podcast Type:
Diabetes Core
Publication Date:
Wednesday, June 24, 2015 - 00:00